Q1 Trading Statement

London & Quadrant Housing Trust
08 August 2025
 

London & Quadrant Housing Trust Trading Update for the period ending 30 June 2025

 

London & Quadrant Housing Trust ('L&Q') is today issuing its consolidated unaudited trading update for the three months ended 30 June 2025 ('2025 Q1'). All statement of comprehensive income comparatives are to L&Q's consolidated audited prior year equivalent period being the three months ended 30 June 2024 ('2024 Q1').

 

HIGHLIGHTS

 

·    There are 109,935 homes owned or managed (as at 31 March 2025: 109,659)

·    L&Q has completed 563 new residential homes (2024 Q1: 353)

·    Turnover was £271m (2024 Q1: £273m)

·    EBITDA-MRI1 was £120m (2024 Q1: £110m)

·    EBITDA-MRI margin2 was 46% (2024 Q1: 39%)

·    EBITDA-MRI margin (excluding sales)3 was 54% (2024 Q1: 49%)

·    Gross sales EBITDA-MRI margin4 was 8% (2024 Q1: 20%)

·    Net sales EBITDA-MRI margin5 was (4%) (2024 Q1: 11%)

·    EBITDA-MRI interest cover6 was 217% (2024 Q1: 179%)

·    EBITDA-MRI social housing lettings interest cover7 was 224% (2024 Q1: 148%)

·    Operating surplus was £120m (2024 Q1: £112m)

·    Debt to assets8 was 39% (2024 Q1: 40%)

·    Sales as a % of turnover10 was 18% (2024 Q1: 24%)

 

Commenting on the results Ed Farnsworth, Executive Group Director, Finance said:

"L&Q's Q1 unaudited results reflect ongoing delivery against our corporate strategy, which is focused on prioritising investment in existing homes and services.

 

We're now three years into our Major Works Investment Programme that has seen us deliver over 16,000 improvements to residents' homes to date. We're on track to deliver around 9,000 more this year, and in Q1, upgraded 196 kitchens, 192 bathrooms, 204 windows and 17 roofs, alongside other building improvements. In ensuring the safety of our homes, we have committed to protect residents from extra costs wherever possible, and our EBITDA-MRI of £120m (2024 Q1: £110m) includes the recovery of significant remediation costs at one of our schemes.

 

We recently announced our plans to combine L&Q's Property Services and Development & Sales directorates into a new Property and Investment directorate. This change will further improve our efficiency and enable us to take a more holistic and effective approach to managing the quality of new and existing homes across the full lifetime of each property.

 

We continue to progress the sale of Metra Living, L&Q's private rented sector business, announced last November, and the transfer of 3,500 homes in South Bucks announced in March 2025. Both are part of a clear strategy to simplify our business and focus on areas where we have the greatest concentration of homes, enabling us to provide more efficient and better value services for residents.

 

We welcomed the clear signal from government in June's Comprehensive Spending Review that it is serious about tackling the housing crisis, and we are engaging with government to work through the detail behind the announcements. We continue to seek opportunities to deliver new affordable and social housing where it does not divert from our strategic aim to derisk our business and prioritise investment in existing homes. During the quarter we marked several key development milestones, including the 'topping out' of our Prime Point scheme in Greenwich, through which we are delivering 476 new homes, of which 70% will be affordable."

 

FORWARD GUIDANCE FOR THE YEAR ENDING 31 MARCH 2026

 

We project operating surplus between £340m - £360m and EBITDA-MRI in the range of £270m to £290m. We forecast gross capital expenditure11 to be c. £314m as our development pipeline slows. We expect to deliver c. 2,069 new residential homes of which c. 73% are expected to be affordable.

 

Financial Metrics

Forward Guidance to 31 March 2026

EBITDA-MRI margin2

26% - 28%

EBITDA-MRI margin (excluding sales)3

30% - 35%

Gross sales EBITDA-MRI margin4

c.3%

EBITDA-MRI interest cover6

145% - 155%

EBITDA-MRI Social housing lettings interest cover7

155% - 165%

Debt to assets8

<33%

Gross debt to EBITDA-MRI9

<15x

Sales as a % of turnover10

< 23%

 

HOUSING COMPLETIONS

L&Q, including joint ventures, has completed 563 (2024 Q1: 353) residential homes in the financial year to date. This comprises of 428 (2024 Q1: 238) completions for social housing tenures (76%) and 135 (2024 Q1: 115) completions for market tenures (24%). During that same time 329 new build residential homes commenced on site (2024 Q1: 228) with the majority of starts being later phases of existing developments.

DEVELOPMENT PIPELINE

L&Q, including joint ventures, is operating from 87 (2024 Q1: 106) active sites. L&Q has approved 13 (2024 Q1: 0) homes during the financial year bringing total homes in the approved development pipeline to 8,341 (2024 Q1: 10,506), of which 65% are currently on site. Of the homes approved in the development pipeline 49% are for social housing tenures and 51% are for market tenures. L&Q holds a further potential 25,480 (2024 Q1: 83,198) strategic land plots.

The future projected cost of the entire development pipeline (including work in progress and developments not yet committed or on site) that extends until the financial year ending 31 March 2040 is estimated at £1.9bn (2024 Q1: £2.4bn) of which £1.3bn (69%) is currently committed (2024 Q1: £1.8bn).

UNAUDITED FINANCIALS

The unaudited financials exclude further adjustments that are subject to audit review.


Statement of Comprehensive Income

 

2025 Q1  

(£m)

2024 Q1

 (£m)

Change

Turnover

 

 

 

Non-sales

233

218


Sales

37

55


 

271

273

(1)%

Operating costs and cost of sales

 

 

 

Non-sales

(144)

(138)


Sales

(38)

(49)


 

(182)

(187)

 3%

Surplus on disposal of fixed assets and investments

32

26


Share of profits from joint ventures

(1)

-


Change in value of investment property

-

-


Operating surplus

120

112

7%

Net interest charge

(51)

(58)


Other finance income/ (costs)

(1)

(1)


Taxation

-

-


Surplus for the period after tax

67

53

26%

 

EBITDA-MRI and Net Cash Interest Paid

 

2025 Q1 

(£m)

2024 Q1

 (£m)

Change

Operating surplus

120

112


Change in value of investment property

-

-


Amortised government grant

(7)

(6)


Depreciation

27

26


Impairment

-

-


Capitalised major repairs

(20)

(22)


EBITDA-MRI

120

110

9% 





Net interest charge

(50)

(57)


Capitalised interest

(5)

(4)


Net cash interest paid

 

Statement of Financial Position

 

2025 Q1 

(£m)

31 March 2025 (£m)

Change (£m)

Housing properties

11,870

11,814

56

Other fixed assets

93

93

-

Investments

1,586

1,587

(1)

Net current assets

89

113

(24)

Total assets less current liabilities

13,638

13,607

31

 

Loans due > one year

 

5,385

 

5,415

 

(30)

Unamortised grant liabilities

1,989

1,996

(7)

Other long-term liabilities

428

427

1

Capital and reserves

5,836

5,769

67

Total non-current liabilities and reserves

13,638

13,607

31

 

Non-Sales Activities

 

2025 Q1 

(£m)

2024 Q1

 (£m)

Change (£m)

Net rents receivable

211

205

6

Charges for support services

1

2

(1)

Amortised government grants

7

6

1

Other income

14

5

9

Turnover

233

218

15

Management costs

(21)

(19)

(2)

Service costs

(28)

(30)

2

Maintenance costs

(57)

(54)

(3)

Support costs

(1)

(3)

2

Depreciation & impairment

(27)

(26)

(1)

Other costs

(9)

(7)

(2)

Operating costs

(144)

(138)

(5)

Surplus on disposal of fixed assets

32

26

6

Change in value of investment property

-

-

-

Operating surplus

121

105

16

 

Arrears

 

Current tenant arrears for all tenures are at 5.43% (as at 31 March 2025: 5.20%).

Sales Activities

 

The cost of sales is inclusive of capitalised interest and overhead costs:

 

2025 Q1 

(£m)

2024 Q1

 (£m)

Change (£m)

Property sales income

37

46

(9)

Land sales income

-

9

(9)

Turnover from sales (excluding JV's)

37

55

(18)

Cost of property sales

(33)

(41)

8

Cost of land sales

-

(2)

2

Operating costs

(5)

(6)

1

Impairment

-

-

-

Total costs (excluding JV's)

(38)

(49)

11

Operating Surplus (excluding JV's)

(1)

6

(7)

Joint venture turnover

12

12

-

Joint venture cost of sales

(11)

(11)

-

Joint venture operating costs

(3)

(1)

(2)

Impairment of investment in JV's

-

-

-

Share of profits from joint ventures

(1)

-

(1)

 

AVERAGE SELLING PRICE

 

The average selling price, including JVs, for outright market sales during the financial year to date was £440k (2024 Q1: £417k). The average selling price of first tranche shared ownership sales during the financial year to date was £425k (2024 Q1: £406k) with an average first tranche sale of 30% (2024 Q1: 32%).

 

SALES MARGINS

 

The cost of sales is inclusive of capitalised interest and overhead costs but excludes impairment:

 

 

Shared

Owner-

ship

Outright

Sales (Non-JV)

Land Sales

Outright Sales (JV's)

2025 Q1

 2024 Q1

Change


(£m)

(£m)

(£m)

(£m)

(£m)

(£m)


Turnover

24

13

-

12

49

67

(18)

Cost of sales

(22)

(12)

-

(11)

(45)

(54)

9

Gross profit

2

1

-

1

4

13

9

Gross EBITDA margin

8%

8%

-

8%

8%

20%

12%

Operating costs

(2)

(1)

-

(3)

(6)

(7)

1

Operating surplus

-

-

-

(2)

(2)

6

(8)

Net EBITDA margin

0%

0%

-

(17%)

(4%)

9%

13%

 

UNSOLD STOCK

 

As at 30 June 2025, L&Q, including joint ventures, held 654 completed homes as unsold stock with a projected revenue of £100m. Projected revenue for shared ownership assumes a first tranche sale of 25%.

 

Of the total unsold stock, 6% has been held as stock for less than one month and 83% is for shared ownership, a tenure where we would expect to continue to show a higher comparative level of unsold stock due to bulk handovers in short time periods and limitations to pre-sale meaning gradual sales rates. In the year to date, L&Q has handed over 89 and sold 194 shared ownership homes.

 

L&Q's forward order book excluding joint ventures consists of 68 exchanged homes with projected revenue of £23m and 176 reservations with projected revenue of £24m.

 

Tenure

Projected Revenue (£m)

No. of Homes

<1 Month

1-3 Months

3-6 Months

6-12 Months

>12 Months

Shared Ownership

66

540

29

73

24

133

281

Outright Sale (non-JV's)

11

23

2

5

-

11

5

Total excluding JV's

77

563

31

78

24

144

286

Outright Sale (JCA's)

2

4

-

-

-

3

1

Outright Sale (JCE's)

21

87

5

54

18

3

7

Total Joint Ventures

23

91

5

54

18

6

8

Total Unsold Stock

100

654

36

132

42

150

294

 

NET DEBT AND LIQUIDITY

 

As at 30 June 2025, net debt (excluding derivative financial liabilities) was £5,378m (as at 31 March 2025: £5,428m) and available liquidity within the group in the form of committed un-drawn revolving credit facilities and non-restricted cash was at £1,101m (as at 31st March 2025: £1,051m). Approximately 54% of L&Q's loan facilities and 64% of drawn loan facilities are at a fixed cost. L&Q has £695m of debt maturities within the next 12 months.

 

UNENCUMBERED ASSETS

 

 

2025 Q1

 

31 March 2025

No. of homes owned or managed

109,935

109,659

No. of social housing homes provided as collateral against debt facilities

(51,327)

(54,566)

No. of private rented homes provided as collateral against debt facilities

(1,295)

(1,295)

Total no. of unencumbered homes owned or under management

57,313

53,798

% of homes under management held as collateral against debt facilities

48%

51%

Unencumbered asset ratio12

46%

46%

 

L&Q CREDIT RATINGS

 

As at date of trading statement release:

 

Rating Agency

S&P

Moody's

Fitch

Long-term credit ratings

BBB+/Stable

A3/Stable

A+/Negative

 

Notes:

1 Operating surplus - change in value of investment properties - amortised government grant + depreciation + impairment - capitalised major repairs +/- actuarial losses/gains in pension schemes

2 EBITDA-MRI / (turnover + turnover from joint ventures - amortised government grant)

3 EBITDA-MRI from non-sales activities / turnover from non-sales activities

4 Gross profit from sales + impairment / turnover from sales including joint ventures

5 Operating surplus from sales + impairment / turnover from sales including joint ventures

6 EBITDA-MRI / net cash interest paid

7 EBITDA-MRI from social housing lettings / net cash interest paid

8 Net debt (excluding derivative financial liabilities) / total assets less current liabilities

9 Gross debt / EBITDA-MRI

10 Sales turnover (including joint ventures) / (turnover plus turnover from joint ventures)

11 Capitalised development expenditure + acquisition of investment property + purchase of other fixed assets

12 100% less (loans due after more than 1 year + derivative liabilities + unamortised grant liability) / total assets less current liabilities

 

This trading update contains certain forward-looking statements about the future outlook for L&Q. Although the Directors believe that these statements are based upon reasonable assumptions, any such statements should be treated with caution as the future outlook may be influenced by factors that could cause actual outcomes and results to be materially different.

 

For further information, please contact:

investors@lqgroup.org.uk

 

James Howell, Director of Partnerships                     020 8189 1596

 

www.lqgroup.org.uk

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings